A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.

Eitemau Tebyg

• Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.
  gan: Hanke, T, et al.
  Cyhoeddwyd: (2005)
• Induction of long-lasting multi-specific CD8+ T cells by a four-component DNA-MVA/HIVA-RENTA candidate HIV-1 vaccine in rhesus macaques.
  gan: Im, E, et al.
  Cyhoeddwyd: (2006)
• Development of a DNA-MVA/HIVA vaccine for Kenya.
  gan: Hanke, T, et al.
  Cyhoeddwyd: (2002)
• Immunogenicity and efficacy of DNA/MVA HIV vaccines in rhesus macaque models
  gan: Lynette Siv Chea, et al.
  Cyhoeddwyd: (2017-10-01)
• Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya.
  gan: Hanke, T, et al.
  Cyhoeddwyd: (2002)